AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20795925
Drug: Student-led progressive
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Student-led progressive resistance training program (6 exercises using weight machines, performed twice a week for 10 weeks, 3 sets of 12 repetitions or until fatigue)
Trial: 17703101
Drug: Skin prick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skin prick test at a concentration of 1 mg/ml
Trial: 17703101
Drug: Intradermal test
RxNorm normalized name: Skin Test Antigens, Multiple Intradermal Test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal test at a concentration of 0.1 mg/ml
Trial: 17703101
Drug: Skin test
RxNorm normalized name: SKIN TEST
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Skin test administered before chemotherapy
Trial: 14727246
Drug: Concomitant chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant chemoradiotherapy with weekly carboplatin/paclitaxel and daily subcutaneous amifostine
Trial: 14727246
Drug: Concomitant chemoradiotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concomitant chemoradiotherapy with weekly carboplatin/paclitaxel without daily subcutaneous amifostine
Trial: 31576651
Drug: Conventional preoperative
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional preoperative preparation (Control)
Trial: 23097398
Drug: Large FSH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large FSH dose (150 mg, n=18)
Trial: 23097398
Drug: Medium FSH
RxNorm normalized name: TRIGLYCERIDES,MEDIUM CHAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medium FSH dose (130 mg, n=12)
Trial: 23097398
Drug: Small FSH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Small FSH dose (80 mg, n=7)
Trial: 16618293
Drug: Propofol 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 2.5 mg x kg(‐1) preceded by fentanyl 3.0 microg x kg(‐1)
Trial: 16618293
Drug: Propofol 3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 3.0 mg x kg(‐1) preceded by fentanyl 3.0 microg x kg(‐1)
Trial: 16618293
Drug: Propofol 3.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol 3.5 mg x kg(‐1) preceded by fentanyl 3.0 microg x kg(‐1)
Trial: 7068935
Drug: Erythromycin base
RxNorm normalized name: Erythromycin base
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin base (250 mg, four times a day for six days)
Trial: 7068935
Drug: Erythromycin stearate
RxNorm normalized name: Erythromycin Stearate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Erythromycin stearate (250 mg, four times a day for six days)
Trial: 7068935
Drug: Erythromycin ethylsuccinate
RxNorm normalized name: Erythromycin Ethylsuccinate
DrugBank: Erythromycin (DB00199)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Erythromycin ethylsuccinate (250 mg, four times a day for six days)
Trial: 7068935
Drug: Lactose placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactose placebo (control group, 250 mg, four times a day for six days)
Trial: 4061890
Drug: Tamoxifen 20
RxNorm normalized name: tamoxifen 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tamoxifen 20 mg/day (n = 20)
Trial: 27956763
Drug: Oral immunonutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral immunonutrition (IN)
Trial: 27956763
Drug: Oral standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral standard nutrition (Control)
Trial: 24783221
Drug: Ultrarush therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrarush therapy
Trial: 22212646
Drug: 1500 μg
RxNorm normalized name: flunixin
DrugBank: Flunixin (DB11518)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1500 μg vitamin D₃ (group 1)
Trial: 22212646
Drug: Two doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two doses of 3000 μg vitamin D₃ (group 2)
Trial: 20974030
Drug: Belladonna and
RxNorm normalized name: BELLADONNA AND DERIVATIVES, PLAIN
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Belladonna and opium (B & O) suppository
Trial: 15605190
Drug: Clodronate (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clodronate (800 mg daily for 2 years)
Trial: 12408892
Drug: Nefopam (NEF)
RxNorm normalized name: nefopam
DrugBank: Nefopam (DB12293)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nefopam (NEF) and desmethyl-nefopam (DMN) assayed using HPLC with a mobile phase of buffer and acetonitrile, flow rate 1.5 ml/min.
Trial: 7573921
Drug: Group A
RxNorm normalized name: Blood group A IgM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group A (EM/LIG) - EMLA and intradermal and subdermal 1% lignocaine infiltration
Trial: 7573921
Drug: Group C
RxNorm normalized name: STREPTOCOCCUS ANTIGEN (GROUP C)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group C (PL/LIG) - Placebo cream and 1% lignocaine
Trial: 1976549
Drug: Lamicel tent
RxNorm normalized name: Lamictal
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamicel tent preoperative treatment
Trial: 7283035
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no topical hydrogen peroxide)
Trial: 31379101
Drug: Test formulation
RxNorm normalized name: mumps skin test antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test formulation of teriflunomide
Trial: 31379101
Drug: Reference formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reference formulation of teriflunomide
Trial: 30072191
Drug: Nab-paclitaxel (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nab-paclitaxel (100 mg/m2) followed by FEC
Trial: 26822209
Drug: 3 mg
RxNorm normalized name: boron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 mg melatonin administered for 7 consecutive days
Trial: 26822209
Drug: Matching placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Matching placebo administered for 7 consecutive days
Trial: 24961471
Drug: 4 ml
RxNorm normalized name: ethanol 1.4 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 ml of human fibrin sealant (Tisseel™, Baxter(®) Deerfield, IL, USA) sprayed along the suture line
Trial: 22146491
Drug: Antivenom B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antivenom B (whole IgG molecules)
Trial: 18198641
Drug: Aidi Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aidi Injection (ADI) combined with FOLFOX4 regimen
Trial: 10673673
Drug: Mobilization chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mobilization chemotherapy
Trial: 3519766
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg hydrochlorothiazide twice daily for 4 weeks
Trial: 30125353
Drug: Ivermectin 300
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin 300 mcg/kg/day plus Dihydroartemisinin-Piperaquine (DP)
Trial: 30125353
Drug: Ivermectin 600
RxNorm normalized name: Ivermectin
DrugBank: Ivermectin (DB00602)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ivermectin 600 mcg/kg/day plus Dihydroartemisinin-Piperaquine (DP)
Trial: 30125353
Drug: Ivermectin 0
RxNorm normalized name: ivermectin 0.136 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin 0 mcg/kg/day plus Dihydroartemisinin-Piperaquine (DP)
Trial: 30125353
Drug: Ivermectin (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ivermectin (all doses)
Trial: 25945337
Drug: Liothyronine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liothyronine (50 mcg every morning)
Trial: 23432361
Drug: Melatonin 3
RxNorm normalized name: melatonin 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 3 mg day(-1)
Trial: 16533938
Drug: Abciximab (0.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abciximab (0.25 mg/kg bolus, followed by 0.125 microg/kg/min infusion for 12 hours, plus heparin, 70 U/kg)
Trial: 16533938
Drug: Placebo (placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (placebo bolus and infusion for 12 hours, plus heparin bolus, 140 U/kg)
Trial: 9059953
Drug: Cyclical etidronate
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cyclical etidronate (400 mg daily for 2 weeks) + calcium (500 mg daily for 11 weeks)
Trial: 29528986
Drug: Quadrivalent human
RxNorm normalized name: PAPILLOMAVIRUS HUMAN QUADRIVALENT VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Quadrivalent human papillomavirus vaccine (qHPV; types 6, 11, 16, 18)
Trial: 25634117
Drug: Intravenous nicorandil
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nicorandil (4-12 mg/h)
Trial: 21371155
Drug: Nicotine replacement
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nicotine replacement therapy (NRT) with a selection box containing patch, gum, inhaler, sublingual tablet, oral pouch for 8 weeks after a week of familiarization.
Trial: 2898045
Drug: Intranasal glucagon
RxNorm normalized name: Glucagon
DrugBank: Glucagon (DB00040)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Intranasal glucagon (7.5 mg)
Trial: 30950580
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg Lutein and Zeaxanthin (L+Z)
Trial: 27925283
Drug: Haloperidol (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haloperidol (4 mg oral dose)
Trial: 23549100
Drug: Intravitreal ranibizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal ranibizumab and dexamethasone combination therapy (Group 1)
Trial: 23549100
Drug: Intravitreal ranibizumab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravitreal ranibizumab monotherapy (Group 2)
Trial: 19554090
Drug: Intensive statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive statin therapy aiming for LDL-cholesterol levels below 70 mg/dL
Trial: 19554090
Drug: Standard statin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard statin therapy aiming for LDL-cholesterol levels < or =100 mg/dL
Trial: 15199111
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (1200 mg/day)
Trial: 11748341
Drug: Etidronate therapy
RxNorm normalized name: etidronate
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etidronate therapy (discontinued after 52 weeks)
Trial: 11748341
Drug: Calcium alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium alone (500 mg/d)
Trial: 7751528
Drug: Saline solution
RxNorm normalized name: Unisol 4 Saline Solution
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Saline solution (vehicle)
Trial: 106963
Drug: Oral nonabsorbable
RxNorm normalized name: COLLAGEN HEMOSTAT,ABSORBABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral nonabsorbable antibiotics plus isolation
Trial: 24888857
Drug: Oral antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral antibiotics alone
Trial: 31151076
Drug: Topical human
RxNorm normalized name: thrombin topical human topical solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical human platelet lysate
Trial: 31151076
Drug: Topical Clobetasol
RxNorm normalized name: clobetasol Topical Foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Clobetasol Propionate
Trial: 28093041
Drug: ISM1/BlastAssist (sequential
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ISM1/BlastAssist (sequential media)
Trial: 22018220
Drug: Iloprost in
RxNorm normalized name: iloprost Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iloprost in saline solution for three weeks
Trial: 19583077
Drug: Manual injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual injection of 0.3 ml/kg lidocaine 0.5%
Trial: 19583077
Drug: Automatic pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automatic pump injection of 0.3 ml/kg lidocaine 0.5%
Trial: 16754920
Drug: 125 mL
RxNorm normalized name: 125 ML argatroban 1 MG/ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 125 mL of coffee (200 mg of caffeine)
Trial: 16754920
Drug: Placebo (decaffeinated
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (decaffeinated coffee containing 15 mg of caffeine)
Trial: 2964080
Drug: Distilled water
RxNorm normalized name: Distilled Water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distilled water (400 ml at room temperature)
Trial: 2964080
Drug: Distilled water
RxNorm normalized name: Distilled Water
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Distilled water (400 ml at 4 degrees C)
Trial: 28656452
Drug: Medication Adherence
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medication Adherence Rating Scale (MARS)
Trial: 28656452
Drug: First-generation antipsychotic
RxNorm normalized name: benzethonium chloride / lidocaine hydrochloride Topical Gel [Tecnu First Aid]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: First-generation antipsychotic use
Trial: 23782410
Drug: Vapotherm 2000i
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vapotherm 2000i at 7 L/min
Trial: 23782410
Drug: Fisher &
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fisher & Paykel HHHFNC at 7 L/min
Trial: 23782410
Drug: Vapotherm 2000i
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vapotherm 2000i at 8 L/min
Trial: 23782410
Drug: Fisher &
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fisher & Paykel HHHFNC at 8 L/min
Trial: 14634878
Drug: Stereotactic aspiration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic aspiration and fibrinolysis with 3 mg rTPA
Trial: 14634878
Drug: Conservative treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conservative treatment according to best medical treatment
Trial: 8779363
Drug: Oral benzocaine
RxNorm normalized name: benzocaine Oral Paste
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral benzocaine 20 mg
Trial: 8779363
Drug: Lignocaine 100
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine 100 mg sprayed onto vocal cords
Trial: 8779363
Drug: Nebulised lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised lignocaine 4 ml (4%)
Trial: 11239030
Drug: Loop diuretics
RxNorm normalized name: LOOP DIURETICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loop diuretics (torasemide or frusemide), 3 mg/kg body weight i.v. every 6 h
Trial: 9519355
Drug: Maximal androgen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maximal androgen blockade (goserelin acetate 3.6 mg s.c. once every 4 weeks + flutamide 250 mg 3 x daily)
Trial: 3143576
Drug: Ciprofloxacin (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (1 g for seven days)
Trial: 15667660
Drug: Doxycycline (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (100 mg)
Trial: 31615840
Drug: Doxycycline (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (200 mg)
Trial: 27851679
Drug: Telephone follow-up
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Telephone follow-up (TFU) 4 and 14 days after discharge in addition to conventional treatment
Trial: 22428572
Drug: All-purpose nipple
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All-purpose nipple ointment (APNO)
Trial: 19120717
Drug: Olmesartan medoxomil
RxNorm normalized name: Olmesartan Medoxomil
DrugBank: Olmesartan (DB00275)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olmesartan medoxomil (OM) 20 mg/d, up-titrated to 40 mg/d, then OM/HCTZ 40/12.5 mg/d, and OM/HCTZ 40/25 mg/d
Trial: 16373084
Drug: TACO (600-1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TACO (600-1200 mg DSM)
Trial: 10936148
Drug: Lidocaine inhalation
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine inhalation (5 mg/kg)
Trial: 10936148
Drug: Salbutamol inhalation
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Salbutamol inhalation (1.5 mg)
Trial: 10936148
Drug: Combined lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined lidocaine and salbutamol inhalation
Trial: 3904806
Drug: Short contact
RxNorm normalized name: BenzePrO Short Contact 9.8 % Topical Foam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Short contact therapy with 1%, 2%, and 3% dithranol (30 min)
Trial: 3904806
Drug: Overnight therapy
RxNorm normalized name: Systane Overnight Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Overnight therapy with 1%, 2%, and 3% dithranol
Trial: 29997136
Drug: Alitretinoin 30
RxNorm normalized name: Alitretinoin
DrugBank: Alitretinoin (DB00523)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alitretinoin 30 mg once daily
Trial: 24336915
Drug: Topical ketorolac
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical ketorolac tromethamine, 0.45% (Acuvail), 4 times daily for 3 days before surgery
Trial: 10754614
Drug: Prophylactic antiemetic
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antiemetic therapy (any active treatment)
Trial: 1425820
Drug: Selegiline (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selegiline (10 mg/day) alone or in combination with tocopherol
Trial: 3904132
Drug: Continuous administration
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous administration of Estracyt
Trial: 3904132
Drug: Intermittent administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intermittent administration of Estracyt
Trial: 26296954
Drug: Guadecitabine 60
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Guadecitabine 60 mg/m(2) daily × 5
Trial: 26296954
Drug: Guadecitabine 90
RxNorm normalized name: Capecitabine
DrugBank: Capecitabine (DB01101)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Guadecitabine 90 mg/m(2) daily × 5
Trial: 26296954
Drug: Guadecitabine (various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guadecitabine (various doses)
Trial: 21555686
Drug: Axitinib plus
RxNorm normalized name: Axitinib
DrugBank: Axitinib (DB06626)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Axitinib plus docetaxel (docetaxel 80 mg/m2 once every 3 weeks plus axitinib 5 mg twice per day)
Trial: 21555686
Drug: Placebo plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo plus docetaxel (docetaxel 80 mg/m2 once every 3 weeks plus placebo)
Trial: 16931508
Drug: Cabergoline (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cabergoline (2 mg single evening dose)
Trial: 10833188
Drug: 500 ml
RxNorm normalized name: TPN Bag 500 mL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 ml bottle
Trial: 9061387
Drug: Oral misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral misoprostol (100 micrograms every 3 hours)
Trial: 4032272
Drug: 4 X
RxNorm normalized name: Mepilex AG 4 x 4"
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 X 100‐mg chewable tablets chewed before swallowing (CHEW)
Trial: 4032272
Drug: 2 X
RxNorm normalized name: anti-HER2 x HER2 ADC
DrugBank: Zanidatamab zovodotin (DB15472)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 X 200‐mg conventional tablets (CT)
Trial: 4032272
Drug: 4 X
RxNorm normalized name: Mepilex AG 4 x 4"
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 X 100‐mg chewable tablets swallowed whole (SW)
Trial: 4032272
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg b.i.d. (projected steady-state)
Trial: 4032272
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg b.i.d. (steady state)
Trial: 17588301
Drug: Prolonged-release nicotinic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prolonged-release nicotinic acid (Niaspan) at a maximum dose of 2000 mg/day
Trial: 2339081
Drug: Intravenous cholecystography
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cholecystography
Trial: 373995
Drug: Indoprofen 600
RxNorm normalized name: Neoprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Indoprofen 600 mg daily
Trial: 31111678
Drug: ramucirumab as
RxNorm normalized name: Ramucirumab
DrugBank: Ramucirumab (DB05578)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: ramucirumab as a single agent
Trial: 31111678
Drug: apatinib as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: apatinib as a third-line or later treatment
Trial: 31111678
Drug: ramucirumab plus
RxNorm normalized name: Ramucirumab
DrugBank: Ramucirumab (DB05578)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: ramucirumab plus immune checkpoint inhibitors
Trial: 31111678
Drug: apatinib in
RxNorm normalized name: Product containing lapatinib in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: apatinib in combination with cytotoxic agents
Trial: 30518584
Drug: Establishment of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Establishment of a trauma treatment team in the experimental group
Trial: 30518584
Drug: Basic treatments
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic treatments in both experimental and control groups
Trial: 29908775
Drug: Insulin resistance
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin resistance (measured by HOMA-IR)
Trial: 15470334
Drug: Nitroflurbiprofen (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroflurbiprofen (100 mg)